Krsnaa diagnostics Limited has completed its quarterly regulatory filing by submitting the confirmation certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 31, 2026. The submission was made to both major stock exchanges on April 04, 2026, demonstrating the company's commitment to regulatory compliance.

Regulatory Compliance Details

The certificate was issued by KFin Technologies Limited, which serves as the registrar and share transfer agent for Krsnaa Diagnostics Limited. KFin Technologies Limited holds SEBI Registration Number INR000000221, authorizing it to perform these regulatory functions. The certificate confirms that all required details regarding securities dematerialized and rematerialized during the specified quarter have been properly furnished to stock exchanges.

Stock Exchange Notifications

The compliance certificate was simultaneously submitted to both major Indian stock exchanges where Krsnaa Diagnostics shares are traded. The company maintains its listing presence across these platforms, ensuring comprehensive regulatory coverage.

Certificate Authentication

The submission was authenticated by Sujay Sudipta Bose, Company Secretary and Compliance Officer of Krsnaa Diagnostics Limited. The document bears digital signatures dated April 04, 2026, ensuring proper authorization and compliance with electronic filing requirements. KFin Technologies Limited's Vice President Dnyanesh Gharote signed the certificates on behalf of the registrar.

Regulatory Framework

Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 mandates that registrars and share transfer agents provide quarterly confirmations regarding dematerialization and rematerialization activities. This requirement ensures transparency in securities handling and maintains investor confidence in the depository system. The regulation applies to all listed companies and their appointed registrars, forming a crucial part of India's securities market infrastructure.

The timely submission of this certificate reflects Krsnaa Diagnostics Limited's adherence to regulatory timelines and its commitment to maintaining good corporate governance practices. Such compliance activities are essential for listed companies to maintain their standing with regulatory authorities and stock exchanges.

Krsnaa Diagnostics Limited has informed stock exchanges about the resignation of Mr. Vivek Jain from his position as Head-Investor Relations, marking a change in the company's senior management personnel.

Resignation Details

The company filed the intimation with BSE and NSE on March 27, 2026, pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Mr. Jain's resignation will be effective from the close of business hours on March 31, 2026.

Management Response

The company's management has placed on record its sincere appreciation for Mr. Jain's valuable contributions and services during his tenure. Company Secretary and Compliance Officer Sujay Sudipta Bose signed the regulatory filing, confirming the resignation details.

Transition Arrangements

In his resignation letter addressed to the Managing Director, Mr. Jain expressed gratitude for the opportunities and professional exposure received during his association with Krsnaa Diagnostics Limited. He described his tenure as "both enriching and rewarding" and acknowledged the trust and confidence placed in him.

Mr. Jain has committed to ensuring a smooth and orderly transition during his notice period, extending complete cooperation in handing over responsibilities to maintain operational continuity. He confirmed that there are no material reasons for his resignation beyond the personal reasons stated.

Regulatory Compliance

The resignation disclosure follows SEBI Master Circular requirements, with the company providing requisite details as mandated. The filing includes comprehensive information about the departure, ensuring full transparency with stakeholders and regulatory authorities.